| 1 |
25503930 | Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. | 2015 Feb |
1 |
| 2 |
26396545 | Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography. | 2015 |
2 |
| 3 |
23274568 | Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis. | 2013 May 1 |
1 |
| 4 |
15570007 | Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. | 2004 Nov 15 |
1 |
| 5 |
11245490 | Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. | 2001 Feb 15 |
1 |
| 6 |
11507063 | Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. | 2001 Aug 15 |
3 |
| 7 |
8653697 | Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. | 1996 Jun 1 |
2 |